CDMO Technology Domain
Advanced Formulation
State-of-the-art dosage form engineering: polymeric sustained-release matrices, lipid-based drug delivery, enteric-coated capsules, and novel excipient selection.
59
dossiers
Precision Microbiome & Gut-Brain Axis
Autonomic Stress Modulation by Nutraceutical, Microbiota-Directed, and Sensory Agents: An Evidence Synthesis with Pathway Map
Formulating nutraceuticals for reliable and context-specific autonomic stress modulation, particularly through gut-brain axis pathways, is challenging due to the variability in cardiac-vagal indices and the lack of robust, direct evidence for broad 'parasympathetic activation' claims.
Precision Microbiome & Gut-Brain Axis
Evidence Review of Oral and Microbiota-Directed Bioactives for Cardiac Vagal Modulation and Physiological Relaxation
The primary challenge for formulators is to develop and substantiate 'vagus activating' or 'parasympathetic activating' ingredients with direct, robust human evidence of cardiac vagal modulation, moving beyond indirect stress markers that lack clinical specificity.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Efficacy of Single-Ingredient Oral Supplements on Objective and Subjective Sleep Outcomes in Adult Insomnia
Developing single-ingredient oral supplements for insomnia faces challenges in achieving consistent objective efficacy due to variations in formulation standardization, optimal dosing, and specific population characteristics, leading to heterogeneous clinical outcomes.
Catecholamine Homeostasis & Executive Function
Oral Bioactives for Sleep & Autonomic Function: Efficacy & Hot Beverage Sachet Delivery
Despite robust evidence for oral bioactives in capsules/tablets improving objective sleep and autonomic indices, there is a critical lack of formulation-specific data supporting their stability, bioavailability, and clinical efficacy when delivered via hot-beverage sachet formats.
Post-GLP-1 Metabolic Optimization
Evidence-Based Dietary Patterns, Ultra-Processed Foods, and Sodium-Potassium Balance: 2025-2026 Insights
Translating nuanced dietary evidence regarding food processing, quality, and electrolyte balance into convenient, effective, and compliant nutritional products for specific patient populations is a complex CDMO challenge. Ensuring palatability and long-term adherence to these precise formulations adds further difficulty.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Medical Foods and Foods for Special Medical Purposes: Regulatory Frameworks and Clinical Nutrition Across Key Regions
Navigating the complex and divergent regulatory frameworks for medical foods in the US and FSMPs in the EU/GCC makes consistent product development, labelling, and market access a significant hurdle for specialized clinical nutrition.
Glycolysis-Restricted FSMP (Oncology Nutrition)
Foods for Special Medical Purposes in Oncology: Nutrition Support & Oral Mucositis Adjunct
Developing clinically substantiated Foods for Special Medical Purposes (FSMPs) and medical foods for cancer patients is challenging due to diverse nutritional needs, metabolic derangements, and specific treatment toxicities like oral mucositis, requiring regulatory diligence and demonstrated efficacy.
Microvascular Hemodynamics & Endothelial Integrity
Erythritol and Human Health, 2020–2026: A PRISMA-Style Systematic Evidence Synthesis
Formulators face the critical challenge of ensuring product safety and consumer trust when using erythritol, given emerging data on its acute cardiovascular effects and potential long-term risks, especially at high intake levels common in ketogenic or diabetic products.
Intracellular Defense & IV-Alternatives
Integrated Metabolic Pathways for Immune Support, Fatigue Reduction, and Cellular Protection: A Mechanistic Review
Designing effective nutritional or pharmaco-nutritional interventions is challenging given the complex, interconnected nature of metabolic pathways supporting immunity, energy, and cellular protection. Delivering pleiotropic compounds efficiently to multiple intracellular targets without systemic burden is critical.
Transmucosal Delivery & Dosage Form Engineering
Systemic Errors in Dietary Supplement Formulation: Mineral Antagonisms, Cofactor Omissions, and Non-Bioidentical Forms
Many dietary supplements fail to achieve intended efficacy due to fundamental formulation errors, including unaddressed mineral antagonisms, omission of critical cofactors, and the use of non-bioidentical molecular forms, leading to poor bioavailability and suboptimal patient outcomes.
Precision Microbiome & Gut-Brain Axis
Enteric-Targeted Butyrate Delivery for Vagal Nerve Stimulation: Addressing Gastric Degradation and Organoleptic Challenges
Designing oral butyrate formulations is challenged by premature gastric dissolution, proximal absorption, and severe organoleptic issues, preventing effective distal gut targeting and patient adherence.
Transmucosal Delivery & Dosage Form Engineering
Isomeric Stabilization in High-Moisture Matrices: Manufacturing Controls for Protecting Fixed-Ratio Inositol Formulations
Maintaining precise fixed component ratios in solid oral formulations, especially those involving moisture-sensitive active ingredients like inositol, is challenging due to segregation during processing and moisture-driven changes in material properties. This leads to content uniformity failures and compromised dosing accuracy.
Glycolysis-Restricted FSMP (Oncology Nutrition)
The Glucose Paradox in Oncology Nutrition: High-Glycemic Medical Foods and Cancer Outcomes
Current sugar-dominant oncology medical foods may inadvertently fuel tumor growth and worsen metabolic dysfunction in cancer patients. Developing nutritionally complete, low-glycemic formulations that support anabolism without pro-oncogenic effects is a critical challenge.
Female Endocrine-Metabolic Crosstalk
Intrapartum Bioenergetics: Rheological Engineering of a Carbohydrate-Based Hydrogel Matrix to Overcome Delayed Gastric Emptying During Active Labour
Developing a carbohydrate-based oral formulation for active labour presents a challenge: it must rapidly deliver energy and prevent neonatal hypoglycemia without exacerbating delayed gastric emptying, increasing aspiration risk, or inducing maternal/neonatal hyperglycemia.
Advanced BBB Permeability Solutions
Lipid Nanoformulations for CNS Delivery of Lipophilic Botanicals: BBB Transport & Catecholaminergic Nootropic Support
Delivering lipophilic botanicals to the central nervous system is hindered by the blood-brain barrier (BBB), rapid metabolism, and low solubility, leading to poor systemic and brain exposure for promising nootropic compounds.
Cellular Longevity & Senolytics
Nano-Micellar Delivery of Hydrophobic Flavonoids for Targeted Senescence Clearance: Overcoming the BCS Class IV Paradox
Hydrophobic flavonoids like fisetin and quercetin face significant formulation constraints due to poor aqueous solubility and low bioavailability, limiting their senolytic therapeutic potential.
Cellular Longevity & Senolytics
Thermodynamic Stability and Degradation Kinetics of Thermolabile Longevity Compounds Under Manufacturing Stress
Thermolabile longevity-associated compounds often degrade significantly during high-shear manufacturing processes, leading to reduced potency and shelf-life. Formulators need robust stability data and strategies to define manufacturable design spaces and protect these sensitive bioactives.
Transmucosal Delivery & Dosage Form Engineering
Physicochemical Instability and Label Discrepancies in Commercial Nutraceuticals: A Global Quality Assessment
Commercial nutraceuticals face pervasive physicochemical degradation and unreliable potency post-manufacturing, compromising efficacy and patient trust. CDMOs must address systemic failures in oxidation control, active ingredient stability, and label accuracy at the point of use.
Transmucosal Delivery & Dosage Form Engineering
Omega-3 Oxidation Quality: TOTOX Index Genesis, Kinetics, Storage, and Clinical Data
Ensuring omega-3 product quality and stability against oxidation to meet stringent TOTOX limits, while mitigating the risk of pro-inflammatory byproducts and ensuring long-term efficacy, presents significant analytical and storage challenges for formulators.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Food Supplements and Medical Foods in Brain Function: A Mechanism-Anchored Evidence Map
Formulators face significant challenges in developing evidence-based brain health supplements due to a lack of clear, mechanism-anchored frameworks for evaluating ingredient efficacy and quality of supporting human data across diverse brain function domains.
Intracellular Defense & IV-Alternatives
Bornaviruses: Genome Organization, Nuclear Replication, and Gene Expression Mechanisms
Developing effective antiviral therapies for nuclear-replicating RNA viruses like Bornaviruses requires deep understanding of their unique genomic organization and complex gene expression mechanisms, posing significant challenges for targeting viral replication without host toxicity.
Cerebral Bioenergetics & Neuro-Metabolic Rescue
Glioblastoma: Epidemiology, Pathology, Molecular Biology, and Therapeutic Landscape
Developing effective glioblastoma therapies is hampered by the tumor's aggressive proliferation, profound intratumoral heterogeneity, and the inherent difficulty in delivering therapeutic agents across the blood-brain barrier to the highly immunosuppressive microenvironment.
Precision Microbiome & Gut-Brain Axis
Norovirus: Virology, Epidemiology, Clinical Disease, Prevention, and Treatment Review
Developing effective norovirus vaccines and direct-acting antivirals is challenged by viral genetic diversity, genotype-specific host tropism, and the absence of a definitive cellular receptor. Current supportive care highlights an urgent need for targeted interventions.
Microvascular Hemodynamics & Endothelial Integrity
Topical Agents in Phlebology: Mechanisms, Efficacy, and Clinical Application Review
Developing stable, bioavailable topical formulations for venous diseases is challenging due to the need for deep tissue penetration and targeted action on microcirculation and inflammation while ensuring patient compliance.
No dossiers match the selected MeSH topic in this page. Try another tag or clear the filter.
Custom Formulation Available
Need a Dossier Built Around Your Molecule?
Our R&D team will conduct a Paid Discovery Audit and build a proprietary clinical dossier for your specific active ingredient or therapeutic target. Full IP transfer included.
RELATED RESOURCES